BONUS - Pressing Pause on the Johnson and Johnson Vaccine

<p>This week, the FDA paused the use of Johnson & Johnson’s COVID-19 vaccine because of reports of six women under 50 who developed a rare form of blood clots called cerebral venous sinus thrombosis. Today, <strong>Stephanie Desmon</strong> talks with <strong>Dr. Josh Sharfstein</strong> about what this means for vaccine rollouts, vaccine hesitancy, and what might happen next. This bonus episode has been lifted from yesterday’s Facebook live which can be seen at www.facebook.com/JohnsHopkinsSPH/.</p>